rethinkTHC Search
Menu
Study breakdown

Older adults had lower baseline endocannabinoid levels but showed larger increases after cannabis use than younger adults

Prospective CohortModerate evidence
The takeaway

In 142 adults aged 21-71, older adults had lower baseline endocannabinoid levels but showed larger acute increases after using cannabis, potentially compensating for age-related decline.

Geriatric medicine researchers, endocannabinoid system scientists, older adult cannabis users

Older adults showed significantly larger AEA and DEA increases after cannabis use

What the researchers found

Older adults (55-71) had lower baseline AEA and DEA vs. younger adults (21-24). After cannabis use, six of seven endocannabinoids increased significantly across all ages. For AEA and DEA, increases were larger in older adults, suggesting cannabis may partially restore age-related endocannabinoid deficits.

Why it matters

Age-related endocannabinoid decline has been linked to chronic pain and neurodegeneration. This study provides the first evidence that cannabis use can acutely boost endocannabinoid levels in older adults, and potentially more than in younger users.

The numbers in context

142 adults (38 younger, 73 midlife, 31 older). Cannabis increased AEA, DEA, LEA, PEA, SEA, OEA across all ages (p < .001). 2-AG did not increase. Larger AEA and DEA increases in older adults (significant Time x Age interaction).

How the study worked

Prospective study of 142 adults in three age groups. Endocannabinoid levels measured before and after cannabis use (1 hour post-flower or 2 hours post-edible). Seven endocannabinoids assayed.

What this study cannot tell us

Small older adult group (n=31). Acute effects only. No placebo control. Unclear whether elevated levels translate to clinical benefit.

How to read the evidence

Prospective design with biomarker measurement across age groups, but small older adult sample and lack of placebo control limit conclusions.

When this study was published

2026 publication

The bigger picture

If cannabis can restore declining endocannabinoid tone in older adults, it may explain why many seniors report benefits from cannabis use and opens questions about whether this represents a therapeutic mechanism.

Questions still open

  • Do the larger increases in older adults translate to greater symptom relief? Would chronic use maintain elevated levels or would tolerance develop?

Common questions

Does the endocannabinoid system decline with age?
This study found older adults had lower levels of key endocannabinoids at baseline, consistent with age-related decline.
Does cannabis work differently in older adults?
It may boost endocannabinoid levels more in older adults, potentially because they start from a lower baseline.

Read the original research

Age differences in endocannabinoid tone are ameliorated after recent cannabis use.

Scientific reports, 16(1), 3483

Citation

Morris, Alan W J; Mueller, Raeghan L; Sempio, Cristina; Klawitter, Jost; Bryan, Angela D; Bidwell, L Cinnamon; Hutchison, Kent E. (2026). Age differences in endocannabinoid tone are ameliorated after recent cannabis use.. Scientific reports, 16(1), 3483. https://doi.org/10.1038/s41598-025-27618-1

Explore the wider topic